LakeShore Biopharma Ownership 2024 | Who Owns LakeShore Biopharma Now?

Overview RevenueFinancials Chart Transcripts

Institutional Ownership

0.00%

Insider Ownership

81.43%

Institutional Holders

13.00

LakeShore Biopharma Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
HHLR ADVISORS, LTD.	-	0.02%	751,790	751,790	100.00%	1,202,864,000	Mar 31, 2023
SNOW LAKE MANAGEMENT LP	-	1.72%	1,811,942	1,811,942	100.00%	2,899,107,000	Mar 31, 2023
PINPOINT ASSET MANAGEMENT LTD	-	0.00%	50,000	50,000	100.00%	7,785,000	Mar 31, 2023
FLOW STATE INVESTMENTS, L.P.	-	0.03%	20,000	20,000	100.00%	32,000,000	Mar 31, 2023
ORBIMED ADVISORS LLC	-	0.14%	4,298,464	4,298,464	100.00%	6,877,542,000	Mar 31, 2023
FMR LLC	-	0.00%	1,165,071	1,165,071	100.00%	1,864,114,000	Mar 31, 2023
RTW INVESTMENTS, LP	-	0.01%	341,090	341,090	100.00%	545,744,000	Mar 31, 2023
FIL LTD	-	0.01%	2,718,499	2,718,499	100.00%	4,349,598,000	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	11,971	11,971	100.00%	19,154,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	13,608	13,608	100.00%	21,772,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	499	499	100.00%	798,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	23,086	23,086	100.00%	37,000	Mar 31, 2023
VALLIANCE ASSET MANAGEMENT LTD	-	4.59%	1,607,175	1,607,175	100.00%	2,571,480,000	Mar 31, 2023

LakeShore Biopharma's largest institutional shareholder is HHLR ADVISORS, LTD., holding 0.00% of the company's total share outstanding, currently valued at $1.20B. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VALLIANCE ASSET MANAGEMENT LTD	-	4.59%	1,607,175	1,607,175	100.00%	2,571,480,000	Mar 31, 2023
SNOW LAKE MANAGEMENT LP	-	1.72%	1,811,942	1,811,942	100.00%	2,899,107,000	Mar 31, 2023
ORBIMED ADVISORS LLC	-	0.14%	4,298,464	4,298,464	100.00%	6,877,542,000	Mar 31, 2023
FLOW STATE INVESTMENTS, L.P.	-	0.03%	20,000	20,000	100.00%	32,000,000	Mar 31, 2023
HHLR ADVISORS, LTD.	-	0.02%	751,790	751,790	100.00%	1,202,864,000	Mar 31, 2023
RTW INVESTMENTS, LP	-	0.01%	341,090	341,090	100.00%	545,744,000	Mar 31, 2023
FIL LTD	-	0.01%	2,718,499	2,718,499	100.00%	4,349,598,000	Mar 31, 2023
PINPOINT ASSET MANAGEMENT LTD	-	0.00%	50,000	50,000	100.00%	7,785,000	Mar 31, 2023
FMR LLC	-	0.00%	1,165,071	1,165,071	100.00%	1,864,114,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	23,086	23,086	100.00%	37,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	499	499	100.00%	798,000	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	11,971	11,971	100.00%	19,154,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	13,608	13,608	100.00%	21,772,000	Mar 31, 2023

The largest LakeShore Biopharma shareholder by % of total assets is VALLIANCE ASSET MANAGEMENT LTD. The company owns 1.61M shares of LakeShore Biopharma (YS), representing 4.59% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ORBIMED ADVISORS LLC	-	0.14%	4,298,464	4,298,464	100.00%	6,877,542,000	Mar 31, 2023
FIL LTD	-	0.01%	2,718,499	2,718,499	100.00%	4,349,598,000	Mar 31, 2023
SNOW LAKE MANAGEMENT LP	-	1.72%	1,811,942	1,811,942	100.00%	2,899,107,000	Mar 31, 2023
VALLIANCE ASSET MANAGEMENT LTD	-	4.59%	1,607,175	1,607,175	100.00%	2,571,480,000	Mar 31, 2023
FMR LLC	-	0.00%	1,165,071	1,165,071	100.00%	1,864,114,000	Mar 31, 2023
HHLR ADVISORS, LTD.	-	0.02%	751,790	751,790	100.00%	1,202,864,000	Mar 31, 2023
RTW INVESTMENTS, LP	-	0.01%	341,090	341,090	100.00%	545,744,000	Mar 31, 2023
PINPOINT ASSET MANAGEMENT LTD	-	0.00%	50,000	50,000	100.00%	7,785,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	23,086	23,086	100.00%	37,000	Mar 31, 2023
FLOW STATE INVESTMENTS, L.P.	-	0.03%	20,000	20,000	100.00%	32,000,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	13,608	13,608	100.00%	21,772,000	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	11,971	11,971	100.00%	19,154,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	499	499	100.00%	798,000	Mar 31, 2023

As of Mar 31 2023, LakeShore Biopharma's largest institutional buyer is ORBIMED ADVISORS LLC. The company purchased 4.30M stocks of YS, valued at $6.88B.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
WOLVERINE ASSET MANAGEMENT LLC	-	-	499	499	100.00%	798,000	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	11,971	11,971	100.00%	19,154,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	13,608	13,608	100.00%	21,772,000	Mar 31, 2023
FLOW STATE INVESTMENTS, L.P.	-	0.03%	20,000	20,000	100.00%	32,000,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	23,086	23,086	100.00%	37,000	Mar 31, 2023
PINPOINT ASSET MANAGEMENT LTD	-	0.00%	50,000	50,000	100.00%	7,785,000	Mar 31, 2023
RTW INVESTMENTS, LP	-	0.01%	341,090	341,090	100.00%	545,744,000	Mar 31, 2023
HHLR ADVISORS, LTD.	-	0.02%	751,790	751,790	100.00%	1,202,864,000	Mar 31, 2023
FMR LLC	-	0.00%	1,165,071	1,165,071	100.00%	1,864,114,000	Mar 31, 2023
VALLIANCE ASSET MANAGEMENT LTD	-	4.59%	1,607,175	1,607,175	100.00%	2,571,480,000	Mar 31, 2023
SNOW LAKE MANAGEMENT LP	-	1.72%	1,811,942	1,811,942	100.00%	2,899,107,000	Mar 31, 2023
FIL LTD	-	0.01%	2,718,499	2,718,499	100.00%	4,349,598,000	Mar 31, 2023
ORBIMED ADVISORS LLC	-	0.14%	4,298,464	4,298,464	100.00%	6,877,542,000	Mar 31, 2023

As of Mar 31 2023, LakeShore Biopharma's biggest institutional seller is WOLVERINE ASSET MANAGEMENT LLC. The company sold 499.00 shares of YS, valued at $798.00K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
ORBIMED ADVISORS LLC	-	0.14%	4,298,464	4,298,464	100.00%	6,877,542,000	Mar 31, 2023
FIL LTD	-	0.01%	2,718,499	2,718,499	100.00%	4,349,598,000	Mar 31, 2023
SNOW LAKE MANAGEMENT LP	-	1.72%	1,811,942	1,811,942	100.00%	2,899,107,000	Mar 31, 2023
VALLIANCE ASSET MANAGEMENT LTD	-	4.59%	1,607,175	1,607,175	100.00%	2,571,480,000	Mar 31, 2023
FMR LLC	-	0.00%	1,165,071	1,165,071	100.00%	1,864,114,000	Mar 31, 2023
HHLR ADVISORS, LTD.	-	0.02%	751,790	751,790	100.00%	1,202,864,000	Mar 31, 2023
RTW INVESTMENTS, LP	-	0.01%	341,090	341,090	100.00%	545,744,000	Mar 31, 2023
PINPOINT ASSET MANAGEMENT LTD	-	0.00%	50,000	50,000	100.00%	7,785,000	Mar 31, 2023
MILLENNIUM MANAGEMENT LLC	-	-	23,086	23,086	100.00%	37,000	Mar 31, 2023
FLOW STATE INVESTMENTS, L.P.	-	0.03%	20,000	20,000	100.00%	32,000,000	Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC	-	-	13,608	13,608	100.00%	21,772,000	Mar 31, 2023
JANE STREET GROUP, LLC	-	-	11,971	11,971	100.00%	19,154,000	Mar 31, 2023
WOLVERINE ASSET MANAGEMENT LLC	-	-	499	499	100.00%	798,000	Mar 31, 2023

LakeShore Biopharma's largest new institutional shareholder by number of shares is ORBIMED ADVISORS LLC, purchased 4.30M shares, valued at $6.88B, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

LakeShore Biopharma Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	13	-

As of 31 Mar 23, 13 institutions are holding LakeShore Biopharma's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	12,813,195	-

LakeShore Biopharma (YS) has 12.81M shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	-	-

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	-	-

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	-	-

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	13	-	12,813,195	-	-	-	-	-	-	-

LakeShore Biopharma Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jan 27, 2022	Rozek Alexander Buffett	director, 10 percent owner	-	P-Purchase	Buy	4,500,000	$10.00	$45.00M	4,500,000
Dec 10, 2020	GLAZER CAPITAL, LLC	10 percent owner	-	S-Sale	Sell	25,000	$10.45	$261.25K	1,323,780
Dec 10, 2020	GLAZER CAPITAL, LLC	10 percent owner	-	S-Sale	Sell	50,000	$10.32	$516.00K	1,348,780

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Jan 27, 2022	Rozek Alexander Buffett	director, 10 percent owner	-	P-Purchase	Buy	4,500,000	$10.00	$45.00M	4,500,000

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Dec 10, 2020	GLAZER CAPITAL, LLC	10 percent owner	-	S-Sale	Sell	25,000	$10.45	$261.25K	1,323,780
Dec 10, 2020	GLAZER CAPITAL, LLC	10 percent owner	-	S-Sale	Sell	50,000	$10.32	$516.00K	1,348,780

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
May 19, 2022	Schmitt Michael Weber	officer	Chief Accounting Officer	A-Award	Buy	20,000	-	-	20,000
May 19, 2022	Adler Gerald	officer	GC & Corporate Secretary	A-Award	Buy	7,500	-	-	7,500
May 19, 2022	Gonzalez Francisco	officer	Chief Financial Officer	A-Award	Buy	150,000	-	-	150,000
May 19, 2022	Jackson Walter	director	-	A-Award	Buy	7,000	-	-	7,000
May 19, 2022	Keinan Tal	director, 10 percent owner, officer	Chief Executive Officer	A-Award	Buy	75,000	-	-	75,000
May 19, 2022	Leiponis Lysa	director	-	A-Award	Buy	7,000	-	-	7,000
May 19, 2022	Nancoo Alethia	director	-	A-Award	Buy	7,000	-	-	7,000
May 19, 2022	Rivkin Robert S.	director	-	A-Award	Buy	7,000	-	-	7,000
Jan 27, 2022	Wellmon Nick	director, 10 percent owner	-	A-Award	Buy	11,640,460	-	-	11,640,460
Jan 27, 2022	Wellmon Nick	director, 10 percent owner	-	A-Award	Buy	11,640,460	-	-	11,640,460
Jan 27, 2022	Jackson Walter	director	-	A-Award	Buy	412,072	-	-	412,072
Jan 27, 2022	Jackson Walter	director	-	A-Award	Buy	412,072	-	-	412,072
Jan 27, 2022	Keinan Tal	director, 10 percent owner, officer	Chief Executive Officer	A-Award	Buy	17,943,792	-	-	17,943,792
Jan 27, 2022	Keinan Tal	director, 10 percent owner, officer	Chief Executive Officer	A-Award	Buy	17,943,792	-	-	17,943,792
Jan 27, 2022	Rozek Alexander Buffett	director, 10 percent owner	-	J-Other	Buy	5,500,000	-	-	13,399,724
Jan 27, 2022	Rozek Alexander Buffett	director, 10 percent owner	-	C-Conversion	Buy	206,250	-	-	7,899,724
Jan 27, 2022	Rozek Alexander Buffett	director, 10 percent owner	-	C-Conversion	Buy	3,193,474	-	-	7,693,474
Jan 27, 2022	Rozek Alexander Buffett	director, 10 percent owner	-	P-Purchase	Buy	4,500,000	$10.00	$45.00M	4,500,000
Dec 10, 2020	GLAZER CAPITAL, LLC	10 percent owner	-	S-Sale	Sell	25,000	$10.45	$261.25K	1,323,780
Dec 10, 2020	GLAZER CAPITAL, LLC	10 percent owner	-	S-Sale	Sell	50,000	$10.32	$516.00K	1,348,780

The last insider sell of LakeShore Biopharma's stock was made by GLAZER CAPITAL, LLC on Dec 10 2020, selling 25,000 shares at $10.45 per share (valued at $261.25K). The last insider buy of YS was made by Rozek Alexander Buffett on Jan 27 2022, buying 4,500,000 shares at $10.00 per share (worth $45.00M).

LakeShore Biopharma Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio

LakeShore Biopharma Peer Ownership

Ticker	Company
ZVSA	ZyVersa Therapeutics, Inc.
BDRX	Biodexa Pharmaceuticals Plc
CNSP	CNS Pharmaceuticals, Inc.
VIRI	Virios Therapeutics, Inc.
REVB	Revelation Biosciences, Inc.
QNRX	Quoin Pharmaceuticals, Ltd.
VRAX	Virax Biolabs Group Limited
EFTR	eFFECTOR Therapeutics, Inc.
ALLR	Allarity Therapeutics, Inc.
IMMX	Immix Biopharma, Inc.
SONN	Sonnet BioTherapeutics Holdings, Inc.
ZURA	Zura Bio Limited
CDIO	Cardio Diagnostics Holdings, Inc.

YS Ownership FAQ

Who Owns LakeShore Biopharma?

LakeShore Biopharma is owned by institutional shareholders (0%), insiders (81.43%), and public (0%). The largest institutional shareholder of LakeShore Biopharma is HHLR ADVISORS, LTD. (0% of total shares) and the top mutual fund owner is (0% of total shares).

Who are the major institutional shareholders of LakeShore Biopharma?

LakeShore Biopharma's major institutional shareholders are HHLR ADVISORS, LTD., SNOW LAKE MANAGEMENT LP, PINPOINT ASSET MANAGEMENT LTD, FLOW STATE INVESTMENTS, L.P., and ORBIMED ADVISORS LLC. The top five shareholders own together 0% of the company's share outstanding.

How many LakeShore Biopharma shareholders are there?

As of Mar 2023, there are 13 institutional shareholders of LakeShore Biopharma.

What percentage of LakeShore Biopharma is owned by HHLR ADVISORS, LTD?

HHLR ADVISORS, LTD owns 751.79K shares of LakeShore Biopharma, representing 0% of the company's total shares outstanding, valued at $1.2B (as of Mar 2023).

What percentage of LakeShore Biopharma is owned by SNOW LAKE MANAGEMENT LP?

As of Mar 2023, SNOW LAKE MANAGEMENT LP holds 1.81M shares of LakeShore Biopharma (YS), compromising 0% of the company, valued at $2.9B.

What percentage of LakeShore Biopharma is owned by PINPOINT ASSET MANAGEMENT LTD?

PINPOINT ASSET MANAGEMENT LTD is the third largest holder of LakeShore Biopharma. The company owns 50K of the company's shares outstanding (worth $7.78M).